Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr Reddys Laboratories clarifies on news item

Date: 21-03-2017

With reference to news flashed on ET Now dated March 21, 2017 quoting ‘US FDA finds repeat observations from 2015 warning letter. Failed to maintain complete data to ensure compliance.’ Dr Reddys Laboratories has submitted a copy of Clarification.

The above information is a part of company’s filings submitted to BSE.